Multiple sclerosis MS Prognosis Amino acid Glutamate Longitudinally extensive transverse myelitis Neuroinflammation Prostate cancer Disease-modifying treatments Aquaporin-4 antibodies CP Neuroscience Neuraxial analgesia Blood-brain barrier Registry Circadian clock Adult neurogenesis Cannabinoid receptor type 2 CD14 GSK-3β B cells Nonactive multiple sclerosis Optic neuritis ON Astrocyte Quality Ependymal cell T follicular helper cells Anti-GFAP encephalomyelitis Perceptual learning Central nervous system Pallidin Breastfeeding Aquaporin-4-IgG AQP4-IgG Biobank Microglia Post-partum Myelin oligodendrocyte glycoprotein Bright Immunosuppressant Cilia Animal model Sleep/wake MOG antibodies Pregnancy Neuromyelitis optica Structural plasticity Olfaction Endocannabinoid system MOG Optogenetic T follicular regulatory cells Connexins Aquaporin-4 GABA Microenvironment Propensity score Neuromyelitis optica spectrum disorders Autoantibodies Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab Clinically isolated syndrome CIS MOG-IgG associated disorders MOGAD Hippocampus Spotty Lateral diffusion Relapses MRI ERRα Neuromyelitis optica spectrum disorders NMOSD Reproductive assistance Disease modifying treatments Glia Sex hormones Collapsing response mediator protein CRMP5 CP Molecular biology Phosphorylation Neuromyelitis optica spectrum disorder Area postrema syndrome Rituximab Bone Multiple sclerosis Sample Drosophila NMOSD Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Autoimmune diseases Sub-ventricular zone Neurite outgrowth LAT1 Children Estradiol Blood brain barrier COVID-19 Treatment response MOGAD Database Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Myelitis Progesterone Optic neuritis Aquaporin-4 antibody Demyelination